nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0746	0.279	CbGbCtD
Alitretinoin—ABCB1—Betamethasone—ankylosing spondylitis	0.0485	0.182	CbGbCtD
Alitretinoin—ABCB1—Prednisolone—ankylosing spondylitis	0.0479	0.179	CbGbCtD
Alitretinoin—ABCB1—Prednisone—ankylosing spondylitis	0.0452	0.169	CbGbCtD
Alitretinoin—ABCB1—Dexamethasone—ankylosing spondylitis	0.0282	0.106	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—ankylosing spondylitis	0.0227	0.0849	CbGbCtD
Alitretinoin—Sweating—Methotrexate—ankylosing spondylitis	0.000346	0.000471	CcSEcCtD
Alitretinoin—Infection—Methylprednisolone—ankylosing spondylitis	0.000345	0.000471	CcSEcCtD
Alitretinoin—Haematuria—Methotrexate—ankylosing spondylitis	0.000344	0.000469	CcSEcCtD
Alitretinoin—Shock—Triamcinolone—ankylosing spondylitis	0.000342	0.000467	CcSEcCtD
Alitretinoin—Insomnia—Prednisolone—ankylosing spondylitis	0.000342	0.000467	CcSEcCtD
Alitretinoin—Alopecia—Prednisone—ankylosing spondylitis	0.000342	0.000467	CcSEcCtD
Alitretinoin—Shock—Methylprednisolone—ankylosing spondylitis	0.000342	0.000466	CcSEcCtD
Alitretinoin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000341	0.000465	CcSEcCtD
Alitretinoin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00034	0.000464	CcSEcCtD
Alitretinoin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00034	0.000464	CcSEcCtD
Alitretinoin—Epistaxis—Methotrexate—ankylosing spondylitis	0.00034	0.000464	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00034	0.000464	CcSEcCtD
Alitretinoin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00034	0.000463	CcSEcCtD
Alitretinoin—Mental disorder—Prednisone—ankylosing spondylitis	0.000339	0.000463	CcSEcCtD
Alitretinoin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000339	0.000462	CcSEcCtD
Alitretinoin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000337	0.00046	CcSEcCtD
Alitretinoin—Erythema—Prednisone—ankylosing spondylitis	0.000337	0.00046	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—ankylosing spondylitis	0.000337	0.00046	CcSEcCtD
Alitretinoin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000336	0.000459	CcSEcCtD
Alitretinoin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000336	0.000459	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000336	0.000458	CcSEcCtD
Alitretinoin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000335	0.000457	CcSEcCtD
Alitretinoin—Convulsion—Betamethasone—ankylosing spondylitis	0.000335	0.000457	CcSEcCtD
Alitretinoin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000334	0.000456	CcSEcCtD
Alitretinoin—Hypertension—Betamethasone—ankylosing spondylitis	0.000334	0.000456	CcSEcCtD
Alitretinoin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000329	0.000449	CcSEcCtD
Alitretinoin—Myalgia—Betamethasone—ankylosing spondylitis	0.000329	0.000449	CcSEcCtD
Alitretinoin—Anxiety—Betamethasone—ankylosing spondylitis	0.000328	0.000448	CcSEcCtD
Alitretinoin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000328	0.000448	CcSEcCtD
Alitretinoin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000325	0.000444	CcSEcCtD
Alitretinoin—Discomfort—Betamethasone—ankylosing spondylitis	0.000325	0.000444	CcSEcCtD
Alitretinoin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000325	0.000444	CcSEcCtD
Alitretinoin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000325	0.000443	CcSEcCtD
Alitretinoin—Pain—Prednisolone—ankylosing spondylitis	0.000324	0.000442	CcSEcCtD
Alitretinoin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000324	0.000441	CcSEcCtD
Alitretinoin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000324	0.000441	CcSEcCtD
Alitretinoin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000321	0.000438	CcSEcCtD
Alitretinoin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000319	0.000436	CcSEcCtD
Alitretinoin—Vision blurred—Prednisone—ankylosing spondylitis	0.000318	0.000433	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000317	0.000433	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000317	0.000433	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000316	0.000432	CcSEcCtD
Alitretinoin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000316	0.000431	CcSEcCtD
Alitretinoin—Oedema—Dexamethasone—ankylosing spondylitis	0.000316	0.000431	CcSEcCtD
Alitretinoin—Oedema—Betamethasone—ankylosing spondylitis	0.000316	0.000431	CcSEcCtD
Alitretinoin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000316	0.000431	CcSEcCtD
Alitretinoin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000315	0.000429	CcSEcCtD
Alitretinoin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000314	0.000429	CcSEcCtD
Alitretinoin—Infection—Dexamethasone—ankylosing spondylitis	0.000314	0.000428	CcSEcCtD
Alitretinoin—Infection—Betamethasone—ankylosing spondylitis	0.000314	0.000428	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000313	0.000427	CcSEcCtD
Alitretinoin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000313	0.000426	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000312	0.000426	CcSEcCtD
Alitretinoin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000312	0.000425	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000312	0.000425	CcSEcCtD
Alitretinoin—Anaemia—Prednisone—ankylosing spondylitis	0.000311	0.000425	CcSEcCtD
Alitretinoin—Shock—Betamethasone—ankylosing spondylitis	0.000311	0.000424	CcSEcCtD
Alitretinoin—Shock—Dexamethasone—ankylosing spondylitis	0.000311	0.000424	CcSEcCtD
Alitretinoin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00031	0.000423	CcSEcCtD
Alitretinoin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00031	0.000423	CcSEcCtD
Alitretinoin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00031	0.000423	CcSEcCtD
Alitretinoin—Agitation—Prednisone—ankylosing spondylitis	0.00031	0.000423	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000309	0.000422	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000309	0.000422	CcSEcCtD
Alitretinoin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000308	0.000421	CcSEcCtD
Alitretinoin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000308	0.000421	CcSEcCtD
Alitretinoin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000306	0.000418	CcSEcCtD
Alitretinoin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000306	0.000417	CcSEcCtD
Alitretinoin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000306	0.000417	CcSEcCtD
Alitretinoin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000305	0.000417	CcSEcCtD
Alitretinoin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000305	0.000417	CcSEcCtD
Alitretinoin—Malaise—Prednisone—ankylosing spondylitis	0.000304	0.000415	CcSEcCtD
Alitretinoin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000302	0.000412	CcSEcCtD
Alitretinoin—Syncope—Prednisone—ankylosing spondylitis	0.000302	0.000412	CcSEcCtD
Alitretinoin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000302	0.000412	CcSEcCtD
Alitretinoin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000301	0.000411	CcSEcCtD
Alitretinoin—Anorexia—Betamethasone—ankylosing spondylitis	0.000301	0.000411	CcSEcCtD
Alitretinoin—Urticaria—Prednisolone—ankylosing spondylitis	0.000301	0.00041	CcSEcCtD
Alitretinoin—Fatigue—Triamcinolone—ankylosing spondylitis	0.0003	0.000409	CcSEcCtD
Alitretinoin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000299	0.000408	CcSEcCtD
Alitretinoin—Pain—Triamcinolone—ankylosing spondylitis	0.000298	0.000406	CcSEcCtD
Alitretinoin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000296	0.000404	CcSEcCtD
Alitretinoin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000295	0.000403	CcSEcCtD
Alitretinoin—Hypotension—Betamethasone—ankylosing spondylitis	0.000295	0.000403	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000294	0.0004	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—ankylosing spondylitis	0.000292	0.000398	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—ankylosing spondylitis	0.000291	0.000397	CcSEcCtD
Alitretinoin—Chills—Methotrexate—ankylosing spondylitis	0.00029	0.000396	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000288	0.000393	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000288	0.000393	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—ankylosing spondylitis	0.000287	0.000391	CcSEcCtD
Alitretinoin—Myalgia—Prednisone—ankylosing spondylitis	0.000287	0.000391	CcSEcCtD
Alitretinoin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000287	0.000391	CcSEcCtD
Alitretinoin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000286	0.00039	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—ankylosing spondylitis	0.000286	0.00039	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—ankylosing spondylitis	0.000286	0.00039	CcSEcCtD
Alitretinoin—Insomnia—Betamethasone—ankylosing spondylitis	0.000286	0.00039	CcSEcCtD
Alitretinoin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000286	0.00039	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000285	0.000389	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000284	0.000387	CcSEcCtD
Alitretinoin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000284	0.000387	CcSEcCtD
Alitretinoin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000284	0.000387	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—ankylosing spondylitis	0.000283	0.000387	CcSEcCtD
Alitretinoin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000283	0.000387	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—ankylosing spondylitis	0.000282	0.000384	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000282	0.000384	CcSEcCtD
Alitretinoin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000279	0.00038	CcSEcCtD
Alitretinoin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000278	0.000379	CcSEcCtD
Alitretinoin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000278	0.000379	CcSEcCtD
Alitretinoin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000277	0.000377	CcSEcCtD
Alitretinoin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000276	0.000376	CcSEcCtD
Alitretinoin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000275	0.000375	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000275	0.000375	CcSEcCtD
Alitretinoin—Oedema—Prednisone—ankylosing spondylitis	0.000275	0.000375	CcSEcCtD
Alitretinoin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000275	0.000375	CcSEcCtD
Alitretinoin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000275	0.000375	CcSEcCtD
Alitretinoin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000275	0.000375	CcSEcCtD
Alitretinoin—Infection—Prednisone—ankylosing spondylitis	0.000273	0.000373	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000273	0.000372	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000273	0.000372	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—ankylosing spondylitis	0.000272	0.000372	CcSEcCtD
Alitretinoin—Fatigue—Betamethasone—ankylosing spondylitis	0.000272	0.000371	CcSEcCtD
Alitretinoin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000272	0.000371	CcSEcCtD
Alitretinoin—Shock—Prednisone—ankylosing spondylitis	0.000271	0.000369	CcSEcCtD
Alitretinoin—Pain—Betamethasone—ankylosing spondylitis	0.00027	0.000368	CcSEcCtD
Alitretinoin—Pain—Dexamethasone—ankylosing spondylitis	0.00027	0.000368	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00027	0.000368	CcSEcCtD
Alitretinoin—Tachycardia—Prednisone—ankylosing spondylitis	0.000268	0.000366	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—ankylosing spondylitis	0.000267	0.000364	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000266	0.000363	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000265	0.000362	CcSEcCtD
Alitretinoin—Anorexia—Prednisone—ankylosing spondylitis	0.000262	0.000358	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000261	0.000357	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—ankylosing spondylitis	0.00026	0.000355	CcSEcCtD
Alitretinoin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00026	0.000355	CcSEcCtD
Alitretinoin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00026	0.000355	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000258	0.000352	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000258	0.000352	CcSEcCtD
Alitretinoin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000256	0.00035	CcSEcCtD
Alitretinoin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000256	0.000349	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—ankylosing spondylitis	0.000254	0.000347	CcSEcCtD
Alitretinoin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000251	0.000342	CcSEcCtD
Alitretinoin—Urticaria—Betamethasone—ankylosing spondylitis	0.000251	0.000342	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000251	0.000342	CcSEcCtD
Alitretinoin—Dizziness—Prednisolone—ankylosing spondylitis	0.00025	0.000341	CcSEcCtD
Alitretinoin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00025	0.000341	CcSEcCtD
Alitretinoin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00025	0.000341	CcSEcCtD
Alitretinoin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00025	0.000341	CcSEcCtD
Alitretinoin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00025	0.000341	CcSEcCtD
Alitretinoin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00025	0.000341	CcSEcCtD
Alitretinoin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000249	0.00034	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—ankylosing spondylitis	0.000249	0.000339	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000247	0.000337	CcSEcCtD
Alitretinoin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000246	0.000336	CcSEcCtD
Alitretinoin—Cough—Methotrexate—ankylosing spondylitis	0.000246	0.000335	CcSEcCtD
Alitretinoin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000246	0.000335	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—ankylosing spondylitis	0.000244	0.000333	CcSEcCtD
Alitretinoin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000242	0.00033	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00024	0.000327	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—ankylosing spondylitis	0.00024	0.000327	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—ankylosing spondylitis	0.00024	0.000327	CcSEcCtD
Alitretinoin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000239	0.000326	CcSEcCtD
Alitretinoin—Rash—Prednisolone—ankylosing spondylitis	0.000239	0.000326	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000238	0.000325	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000238	0.000325	CcSEcCtD
Alitretinoin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000238	0.000324	CcSEcCtD
Alitretinoin—Fatigue—Prednisone—ankylosing spondylitis	0.000237	0.000324	CcSEcCtD
Alitretinoin—Headache—Prednisolone—ankylosing spondylitis	0.000237	0.000323	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—ankylosing spondylitis	0.000237	0.000323	CcSEcCtD
Alitretinoin—Constipation—Prednisone—ankylosing spondylitis	0.000235	0.000321	CcSEcCtD
Alitretinoin—Confusional state—Methotrexate—ankylosing spondylitis	0.000232	0.000316	CcSEcCtD
Alitretinoin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00023	0.000314	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00023	0.000314	CcSEcCtD
Alitretinoin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00023	0.000313	CcSEcCtD
Alitretinoin—Infection—Methotrexate—ankylosing spondylitis	0.000228	0.000312	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000227	0.000309	CcSEcCtD
Alitretinoin—Asthenia—Betamethasone—ankylosing spondylitis	0.000227	0.000309	CcSEcCtD
Alitretinoin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000227	0.000309	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000225	0.000308	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000225	0.000307	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000225	0.000307	CcSEcCtD
Alitretinoin—Nausea—Prednisolone—ankylosing spondylitis	0.000225	0.000307	CcSEcCtD
Alitretinoin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000223	0.000305	CcSEcCtD
Alitretinoin—Pruritus—Betamethasone—ankylosing spondylitis	0.000223	0.000305	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000223	0.000305	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000222	0.000303	CcSEcCtD
Alitretinoin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000221	0.000302	CcSEcCtD
Alitretinoin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000221	0.000301	CcSEcCtD
Alitretinoin—Rash—Triamcinolone—ankylosing spondylitis	0.000219	0.000299	CcSEcCtD
Alitretinoin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000219	0.000299	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—ankylosing spondylitis	0.000219	0.000299	CcSEcCtD
Alitretinoin—Rash—Methylprednisolone—ankylosing spondylitis	0.000219	0.000299	CcSEcCtD
Alitretinoin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000219	0.000298	CcSEcCtD
Alitretinoin—Urticaria—Prednisone—ankylosing spondylitis	0.000218	0.000298	CcSEcCtD
Alitretinoin—Headache—Triamcinolone—ankylosing spondylitis	0.000218	0.000297	CcSEcCtD
Alitretinoin—Headache—Methylprednisolone—ankylosing spondylitis	0.000218	0.000297	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000217	0.000297	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000217	0.000297	CcSEcCtD
Alitretinoin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000216	0.000295	CcSEcCtD
Alitretinoin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000216	0.000295	CcSEcCtD
Alitretinoin—Hypotension—Methotrexate—ankylosing spondylitis	0.000215	0.000293	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000209	0.000286	CcSEcCtD
Alitretinoin—Dizziness—Betamethasone—ankylosing spondylitis	0.000209	0.000285	CcSEcCtD
Alitretinoin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000209	0.000285	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—ankylosing spondylitis	0.000208	0.000284	CcSEcCtD
Alitretinoin—Nausea—Triamcinolone—ankylosing spondylitis	0.000207	0.000282	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000206	0.000282	CcSEcCtD
Alitretinoin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000206	0.000281	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000205	0.00028	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—ankylosing spondylitis	0.000204	0.000279	CcSEcCtD
Alitretinoin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000203	0.000276	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000202	0.000276	CcSEcCtD
Alitretinoin—Vomiting—Betamethasone—ankylosing spondylitis	0.000201	0.000274	CcSEcCtD
Alitretinoin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000201	0.000274	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0002	0.000273	CcSEcCtD
Alitretinoin—Rash—Betamethasone—ankylosing spondylitis	0.000199	0.000272	CcSEcCtD
Alitretinoin—Rash—Dexamethasone—ankylosing spondylitis	0.000199	0.000272	CcSEcCtD
Alitretinoin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000199	0.000271	CcSEcCtD
Alitretinoin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000199	0.000271	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000198	0.000271	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—ankylosing spondylitis	0.000198	0.00027	CcSEcCtD
Alitretinoin—Headache—Dexamethasone—ankylosing spondylitis	0.000198	0.00027	CcSEcCtD
Alitretinoin—Headache—Betamethasone—ankylosing spondylitis	0.000198	0.00027	CcSEcCtD
Alitretinoin—Asthenia—Prednisone—ankylosing spondylitis	0.000197	0.000269	CcSEcCtD
Alitretinoin—Pain—Methotrexate—ankylosing spondylitis	0.000197	0.000268	CcSEcCtD
Alitretinoin—Pruritus—Prednisone—ankylosing spondylitis	0.000195	0.000265	CcSEcCtD
Alitretinoin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000189	0.000258	CcSEcCtD
Alitretinoin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000188	0.000257	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000188	0.000256	CcSEcCtD
Alitretinoin—Nausea—Dexamethasone—ankylosing spondylitis	0.000188	0.000256	CcSEcCtD
Alitretinoin—Nausea—Betamethasone—ankylosing spondylitis	0.000188	0.000256	CcSEcCtD
Alitretinoin—Urticaria—Methotrexate—ankylosing spondylitis	0.000183	0.000249	CcSEcCtD
Alitretinoin—Dizziness—Prednisone—ankylosing spondylitis	0.000182	0.000248	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000182	0.000248	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000182	0.000248	CcSEcCtD
Alitretinoin—Vomiting—Prednisone—ankylosing spondylitis	0.000175	0.000239	CcSEcCtD
Alitretinoin—Rash—Prednisone—ankylosing spondylitis	0.000173	0.000237	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—ankylosing spondylitis	0.000173	0.000236	CcSEcCtD
Alitretinoin—Headache—Prednisone—ankylosing spondylitis	0.000172	0.000235	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000169	0.000231	CcSEcCtD
Alitretinoin—Asthenia—Methotrexate—ankylosing spondylitis	0.000165	0.000225	CcSEcCtD
Alitretinoin—Nausea—Prednisone—ankylosing spondylitis	0.000163	0.000223	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—ankylosing spondylitis	0.000163	0.000222	CcSEcCtD
Alitretinoin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000157	0.000215	CcSEcCtD
Alitretinoin—Dizziness—Methotrexate—ankylosing spondylitis	0.000152	0.000207	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—ankylosing spondylitis	0.000146	0.000199	CcSEcCtD
Alitretinoin—Rash—Methotrexate—ankylosing spondylitis	0.000145	0.000198	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000145	0.000198	CcSEcCtD
Alitretinoin—Headache—Methotrexate—ankylosing spondylitis	0.000144	0.000196	CcSEcCtD
Alitretinoin—Nausea—Methotrexate—ankylosing spondylitis	0.000137	0.000186	CcSEcCtD
